237 related articles for article (PubMed ID: 8956331)
1. Metabolism, uptake, and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2.
Tamura K; Lee CP; Smith PL; Borchardt RT
Pharm Res; 1996 Nov; 13(11):1663-7. PubMed ID: 8956331
[TBL] [Abstract][Full Text] [Related]
2. Metabolism, uptake, and transepithelial transport of the diastereomers of Val-Val in the human intestinal cell line, Caco-2.
Tamura K; Bhatnagar PK; Takata JS; Lee CP; Smith PL; Borchardt RT
Pharm Res; 1996 Aug; 13(8):1213-8. PubMed ID: 8865315
[TBL] [Abstract][Full Text] [Related]
3. Structure-affinity relationships of Val-Val and Val-Val-Val stereoisomers with the apical oligopeptide transporter in human intestinal Caco-2 cells.
Li J; Tamura K; Lee CP; Smith PL; Borchardt RT; Hidalgo IJ
J Drug Target; 1998; 5(5):317-27. PubMed ID: 9771614
[TBL] [Abstract][Full Text] [Related]
4. Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers.
Satake M; Enjoh M; Nakamura Y; Takano T; Kawamura Y; Arai S; Shimizu M
Biosci Biotechnol Biochem; 2002 Feb; 66(2):378-84. PubMed ID: 11999412
[TBL] [Abstract][Full Text] [Related]
5. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
Han HK; Oh DM; Amidon GL
Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
[TBL] [Abstract][Full Text] [Related]
6. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
Anand BS; Patel J; Mitra AK
J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
[TBL] [Abstract][Full Text] [Related]
7. Substrate specificity of the di/tripeptide transporter in human intestinal epithelia (Caco-2): identification of substrates that undergo H(+)-coupled absorption.
Thwaites DT; Hirst BH; Simmons NL
Br J Pharmacol; 1994 Nov; 113(3):1050-6. PubMed ID: 7858848
[TBL] [Abstract][Full Text] [Related]
8. H(+)-coupled dipeptide (glycylsarcosine) transport across apical and basal borders of human intestinal Caco-2 cell monolayers display distinctive characteristics.
Thwaites DT; Brown CD; Hirst BH; Simmons NL
Biochim Biophys Acta; 1993 Sep; 1151(2):237-45. PubMed ID: 8373798
[TBL] [Abstract][Full Text] [Related]
9. Use of Caco-2 cells and LC/MS/MS to screen a peptide combinatorial library for permeable structures.
Stevenson CL; Augustijns PF; Hendren RW
Int J Pharm; 1999 Jan; 177(1):103-15. PubMed ID: 10205607
[TBL] [Abstract][Full Text] [Related]
10. The apical uptake transporter of levofloxacin is distinct from the peptide transporter in human intestinal epithelial Caco-2 cells.
Fukumori S; Murata T; Takaai M; Tahara K; Taguchi M; Hashimoto Y
Drug Metab Pharmacokinet; 2008; 23(5):373-8. PubMed ID: 18974615
[TBL] [Abstract][Full Text] [Related]
11. Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes.
Inui K; Yamamoto M; Saito H
J Pharmacol Exp Ther; 1992 Apr; 261(1):195-201. PubMed ID: 1560365
[TBL] [Abstract][Full Text] [Related]
12. The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models.
Foltz M; Cerstiaens A; van Meensel A; Mols R; van der Pijl PC; Duchateau GS; Augustijns P
Peptides; 2008 Aug; 29(8):1312-20. PubMed ID: 18490081
[TBL] [Abstract][Full Text] [Related]
13. Comparison of bidirectional cephalexin transport across MDCK and caco-2 cell monolayers: interactions with peptide transporters.
Putnam WS; Pan L; Tsutsui K; Takahashi L; Benet LZ
Pharm Res; 2002 Jan; 19(1):27-33. PubMed ID: 11837697
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of transport of quinapril in Caco-2 cell monolayers: comparison with cephalexin.
Hu M; Zheng L; Chen J; Liu L; Zhu Y; Dantzig AH; Stratford RE
Pharm Res; 1995 Aug; 12(8):1120-5. PubMed ID: 7494822
[TBL] [Abstract][Full Text] [Related]
15. Derivatives of melphalan designed to enhance drug accumulation in cancer cells.
Kupczyk-Subotkowska L; Tamura K; Pal D; Sakaeda T; Siahaan TJ; Stella VJ; Borchardt RT
J Drug Target; 1997; 4(6):359-70. PubMed ID: 9239576
[TBL] [Abstract][Full Text] [Related]
16. Studies on intestinal absorption of sulpiride (2): transepithelial transport of sulpiride across the human intestinal cell line Caco-2.
Watanabe K; Sawano T; Endo T; Sakata M; Sato J
Biol Pharm Bull; 2002 Oct; 25(10):1345-50. PubMed ID: 12392092
[TBL] [Abstract][Full Text] [Related]
17. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2.
Dantzig AH; Bergin L
Biochim Biophys Acta; 1990 Sep; 1027(3):211-7. PubMed ID: 2397233
[TBL] [Abstract][Full Text] [Related]
18. Transepithelial transport characteristics of the antihypertensive peptide, Lys-Val-Leu-Pro-Val-Pro, in human intestinal Caco-2 cell monolayers.
Sun H; Liu D; Li S; Qin Z
Biosci Biotechnol Biochem; 2009 Feb; 73(2):293-8. PubMed ID: 19202266
[TBL] [Abstract][Full Text] [Related]
19. Effect of insulin on cephalexin uptake and transepithelial transport in the human intestinal cell line Caco-2.
Watanabe K; Terada K; Jinriki T; Sato J
Eur J Pharm Sci; 2004 Jan; 21(1):87-95. PubMed ID: 14706815
[TBL] [Abstract][Full Text] [Related]
20. Transport of L-valine-acyclovir via the oligopeptide transporter in the human intestinal cell line, Caco-2.
de Vrueh RL; Smith PL; Lee CP
J Pharmacol Exp Ther; 1998 Sep; 286(3):1166-70. PubMed ID: 9732374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
